W. K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.
Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.
JAMA Ophthalmol. 2020 Jan 1;138(1):76-80. doi: 10.1001/jamaophthalmol.2019.4432.
Opioids, which carry a high risk for addiction and overdose, are commonly prescribed after corneal surgery. Data are lacking describing opioid prescribing practices and opioid needs by patients after ophthalmic surgery.
To quantify opioid use and to assess the association of decreasing the number of opioid tablets prescribed after corneal surgery with postsurgical use.
DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study investigated opioid use after corneal surgery using direct interviews of 2 adult patient cohorts separated by an updated opioid prescribing guideline. The first cohort survey assessed the quantity of opioid tablets used after surgery. The cornea division of a tertiary care academic medical center reviewed the use needs and decreased the number of tablets prescribed after routine cases. Simultaneously, a statewide opioid monitoring program began that provided patients with opioid information. A second unique cohort received a more detailed survey to assess use, opioid disposal, and pain control. Data for the first cohort were collected from December 1, 2017, through January 19, 2018; for the second cohort, from June 1 to September 15, 2018. Data were analyzed from October 24, 2018, through September 24, 2019.
Corneal surgery.
Differences in use of opioid tablets used by both patient cohorts, assessed using the 2-sample t test.
Of 112 eligible, contacted patients, 82 consented to participate (42 men [51%]; mean [SD] age, 42.5 [17.8] years) and were included in the analysis; 38 of 42 participated in the first cohort and 44 of 70 participated in the second cohort. Of those receiving opioid prescriptions, the first cohort was prescribed significantly more tablets than the second cohort (mean [SD], 18.8 [4.2] vs 6.6 [3.1]; difference, 12.2 [95% CI, 10.4-14.0]; P < .001). The first cohort used significantly more tablets than the second cohort (mean [SD], 8.3 [7.0] vs 4.0 [3.2]; difference, 4.3 [95% CI, 1.4-7.2]; P = .005) and had significantly more leftover tablets (mean [SD], 10.3 [6.9] vs 2.9 [2.7]; difference, 7.5 [95% CI, 4.7-10.2]; P < .001). In the detailed survey for the second cohort, 19 of 27 patients reported pain control as adequate (70% [95% CI, 50%-86%]); 6 of 27, as more than needed (22% [95% CI, 9%-42%]). Twenty of 28 participants (71% [95% CI, 55%-88%]) had leftover tablets; 17 of these (85% [95% CI, 62%-97%]) did not dispose of leftovers, and 3 (15% [95% CI, 3%-38%]) threw away or flushed leftovers.
After an assessment of opioid needs, physicians prescribed fewer opioid pills. However, patients who underwent cornea surgery and received fewer tablets continued to have adequate pain control and used even fewer tablets compared with the initial cohort. Patients with unused opioid tablets did not dispose of them properly.
在角膜手术后,通常会开处方开具有较高成瘾和过量风险的阿片类药物。缺乏描述眼科手术后患者阿片类药物使用情况和需求的相关数据。
量化阿片类药物的使用情况,并评估减少角膜手术后阿片类药物处方数量与术后使用之间的关系。
设计、地点和参与者:本前瞻性队列研究使用直接访谈的方式调查了角膜手术后的阿片类药物使用情况,访谈对象为两个成人患者队列,这两个队列分别根据更新的阿片类药物处方指南进行了区分。第一队列的调查评估了手术后使用的阿片类药物片剂数量。一家三级护理学术医疗中心的角膜科审查了使用需求,并减少了常规病例的处方片剂数量。同时,开始了一个全州范围的阿片类药物监测计划,为患者提供阿片类药物信息。第二个独特的队列收到了更详细的调查,以评估使用情况、阿片类药物处置和疼痛控制情况。第一个队列的数据收集时间为 2017 年 12 月 1 日至 2018 年 1 月 19 日;第二个队列的数据收集时间为 2018 年 6 月 1 日至 9 月 15 日。数据分析时间为 2018 年 10 月 24 日至 2019 年 9 月 24 日。
角膜手术。
使用 2 样本 t 检验评估两个患者队列使用的阿片类药物片剂数量的差异。
在 112 名符合条件的、联系过的患者中,有 82 名同意参与(42 名男性[51%];平均[标准差]年龄为 42.5[17.8]岁),并纳入了分析;其中 38 名参与了第一队列,44 名参与了第二队列。接受阿片类药物处方的患者中,第一队列开的片剂明显多于第二队列(平均[标准差],18.8[4.2]对 6.6[3.1];差异,12.2[95%置信区间,10.4-14.0];P<0.001)。第一队列使用的片剂明显多于第二队列(平均[标准差],8.3[7.0]对 4.0[3.2];差异,4.3[95%置信区间,1.4-7.2];P=0.005),且剩余的片剂明显较多(平均[标准差],10.3[6.9]对 2.9[2.7];差异,7.5[95%置信区间,4.7-10.2];P<0.001)。在第二队列的详细调查中,27 名患者中有 19 名报告疼痛控制足够(70%[95%置信区间,50%-86%]);6 名患者报告疼痛控制超过需要(22%[95%置信区间,9%-42%])。27 名参与者中有 20 名(71%[95%置信区间,55%-88%])有剩余的片剂;其中 17 名(85%[95%置信区间,62%-97%])未处置剩余的片剂,3 名(15%[95%置信区间,3%-38%])将剩余的片剂扔掉或冲掉。
在评估阿片类药物需求后,医生开的阿片类药物片剂数量减少。然而,接受角膜手术并开了较少片剂的患者继续有足够的疼痛控制,并且与初始队列相比,他们使用的片剂甚至更少。有未使用的阿片类药物片剂的患者没有正确处理这些药物。